Glenmede Trust CO Na Novo Cure LTD Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $11,216 - $17,414	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $696 - $1,335	-12 Reduced 10.71%	100 $11,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $163,420 - $212,589	-2,857 Reduced 96.23%	112 $6,000
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $7,308 - $10,036	107 Added 3.74%	2,969 $249,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $102,811 - $162,543	1,662 Added 138.5%	2,862 $213,000
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $50,664 - $75,876	1,200 New	1,200 $75,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.